Barker, Mary M. http://orcid.org/0000-0002-5516-8615
Kõiv, Kadri http://orcid.org/0000-0001-5286-2014
Magnúsdóttir, Ingibjörg http://orcid.org/0000-0002-1983-6049
Milbourn, Hannah http://orcid.org/0000-0003-4479-8635
Wang, Bin http://orcid.org/0000-0002-0738-8859
Du, Xinkai
Murphy, Gillian http://orcid.org/0000-0002-7845-1595
Herweijer, Eva
Gísladóttir, Elísabet U.
Li, Huiqi http://orcid.org/0000-0002-1127-0829
Lovik, Anikó http://orcid.org/0000-0002-6397-5011
Kähler, Anna K.
Campbell, Archie http://orcid.org/0000-0003-0198-5078
Feychting, Maria http://orcid.org/0000-0002-5101-0060
Hauksdóttir, Arna
Joyce, Emily E. http://orcid.org/0000-0001-9722-5596
Thordardottir, Edda Bjork
Frans, Emma M.
Hoffart, Asle http://orcid.org/0000-0002-8042-8570
Mägi, Reedik http://orcid.org/0000-0002-2964-6011
Tómasson, Gunnar
Ásbjörnsdóttir, Kristjana http://orcid.org/0000-0002-3263-3457
Jakobsdóttir, Jóhanna
Andreassen, Ole A. http://orcid.org/0000-0002-4461-3568
Sullivan, Patrick F.
Johnson, Sverre Urnes
Aspelund, Thor http://orcid.org/0000-0002-7998-5433
Brandlistuen, Ragnhild Eek
Ask, Helga http://orcid.org/0000-0003-0149-5319
McCartney, Daniel L. http://orcid.org/0000-0003-3242-0360
Ebrahimi, Omid V. http://orcid.org/0000-0002-8335-2217
Lehto, Kelli
Valdimarsdóttir, Unnur A. http://orcid.org/0000-0001-5382-946X
Nyberg, Fredrik http://orcid.org/0000-0003-0892-5668
Fang, Fang http://orcid.org/0000-0002-3310-6456
Funding for this research was provided by:
NordForsk (105668 and 138929, 105668 and 138929, 105668, 105668 and 138929)
EC | Horizon 2020 Framework Programme (847776, 847776, 847776)
Norges Forskningsråd (223273, 324620)
Knut och Alice Wallenbergs Stiftelse (KAW 2021-0010/VC2021.0018)
Vetenskapsrådet (2021-05045 and 2021-05450, ALFGBG-938453, ALFGBG-971130, ALFGBG-978954)
Forskningsrådet om Hälsa, Arbetsliv och Välfärd (2022-00579)
Article History
Received: 11 March 2024
Accepted: 3 September 2024
First Online: 26 September 2024
Competing interests
: EMF received speaker’s honoraria from Astra Zeneca. OAA is a consultant for Cortechs.ai, and received speaker’s honoraria from Janssen, Lundbeck, Sunovion, Otsuka. PFS is a shareholder and on the advisory committee of Neumora Therapeutics. FN owns some AstraZeneca shares. The remaining authors declare no competing interests.